SCN2A Gene Convulsions Benign Familial Infantile 3 Genetic Test sale cost 4400 AED
B3GALNT2 Gene Congenital Muscular Dystrophy and Hypoglycosylation of α-Dystroglycan Genetic Test sale cost 4400 AED B3GALNT2 Gene Congenital Muscular Dystrophy and Hypoglycosylation of Dystroglycan Genetic Test 5,600 د.إ 4,400 د.إ
PRX Gene Dejerine-Sottas Disease Genetic Test sale cost 4400 AED PRX Gene Dejerine-Sottas Disease Genetic Test 5,600 د.إ 4,400 د.إ
Sale!

SCN2A Gene Convulsions Benign Familial Infantile 3 Genetic Test

4,400 د.إ

-21%

The SCN2A Gene Convulsions Benign Familial Infantile 3 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the SCN2A gene, which are linked to Benign Familial Infantile Epilepsy (BFIE) type 3. This condition is characterized by the onset of seizures or convulsions in infants, typically between the ages of 3 months and 12 months. These seizures are generally not associated with long-term neurological deficits, making the condition “benign” in nature. However, early and accurate diagnosis is crucial for the effective management and treatment of the seizures, which can significantly improve the quality of life for affected infants.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, this test offers a comprehensive analysis of the SCN2A gene to detect any mutations that could be responsible for the disorder. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed using advanced genetic sequencing technologies.

The cost of the SCN2A Gene Convulsions Benign Familial Infantile 3 Genetic Test is 4400 AED. This price reflects the intricate processes and sophisticated technology involved in accurately identifying the genetic variations linked to this specific form of epilepsy. By opting for this test, parents and healthcare providers can gain valuable insights into the genetic underpinnings of the infant’s condition, enabling tailored treatment plans and informed decisions about care and management.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SCN2A Gene Convulsions benign familial infantile 3 Genetic Test

Test Details

The SCN2A gene is associated with a rare genetic disorder called benign familial infantile convulsions type 3 (BFIC3). This disorder is characterized by seizures that begin in infancy and typically resolve by the age of two. However, in some cases, seizures may continue into childhood.

NGS genetic testing can be used to identify mutations in the SCN2A gene that are associated with BFIC3. This type of testing involves sequencing the entire gene to identify any changes or mutations that may be present. Genetic testing can help diagnose BFIC3 and can also be used for carrier testing for family members of affected individuals. It can also be used for prenatal testing in families with a known SCN2A mutation.

Early diagnosis and management of BFIC3 can help improve outcomes and prevent complications associated with seizures. Therefore, genetic testing can play an important role in the diagnosis and management of this rare disorder.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for SCN2A Gene Convulsions, benign familial infantile, 3 NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with SCN2A Gene Convulsions, benign familial infantile, 3

Test Name

SCN2A Gene Convulsions benign familial infantile 3 Genetic Test

For more information, please contact DNA Labs UAE.

Test Name SCN2A Gene Convulsions benign familial infantile 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SCN2A Gene Convulsions, benign familial infantile, 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SCN2A Gene Convulsions, benign familial infantile, 3
Test Details

The SCN2A gene is associated with a rare genetic disorder called benign familial infantile convulsions type 3 (BFIC3). This disorder is characterized by seizures that begin in infancy and typically resolve by the age of two. However, in some cases, seizures may continue into childhood.

NGS genetic testing can be used to identify mutations in the SCN2A gene that are associated with BFIC3. This type of testing involves sequencing the entire gene to identify any changes or mutations that may be present.

Genetic testing can help diagnose BFIC3 and can also be used for carrier testing for family members of affected individuals. It can also be used for prenatal testing in families with a known SCN2A mutation.

Early diagnosis and management of BFIC3 can help improve outcomes and prevent complications associated with seizures. Therefore, genetic testing can play an important role in the diagnosis and management of this rare disorder.

SKU: TEST-1211 Category:

Related products